Annual CFI
-$94.18 M
-$35.60 M-60.77%
December 31, 2023
Summary
- As of February 24, 2025, IART annual cash flow from investing activities is -$94.18 million, with the most recent change of -$35.60 million (-60.77%) on December 31, 2023.
- During the last 3 years, IART annual CFI has fallen by -$26.11 million (-38.35%).
- IART annual CFI is now -839.11% below its all-time high of $12.74 million, reached on December 31, 2004.
Performance
IART Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$10.40 M
+$311.80 M+96.77%
September 30, 2024
Summary
- As of February 24, 2025, IART quarterly cash flow from investing activities is -$10.40 million, with the most recent change of +$311.80 million (+96.77%) on September 30, 2024.
- Over the past year, IART quarterly CFI has dropped by -$2.70 million (-35.07%).
- IART quarterly CFI is now -128.12% below its all-time high of $36.97 million, reached on December 31, 2004.
Performance
IART Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$443.79 M
-$2.70 M-0.61%
September 30, 2024
Summary
- As of February 24, 2025, IART TTM cash flow from investing activities is -$443.79 million, with the most recent change of -$2.70 million (-0.61%) on September 30, 2024.
- Over the past year, IART TTM CFI has dropped by -$352.02 million (-383.59%).
- IART TTM CFI is now -3582.88% below its all-time high of $12.74 million, reached on December 31, 2004.
Performance
IART TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IART Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.8% | -35.1% | -383.6% |
| 3 y3 years | -38.4% | -35.1% | -383.6% |
| 5 y5 years | -89.5% | -35.1% | -383.6% |
IART Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.8% | +41.7% | -170.2% | +96.8% | -1320.3% | at low |
| 5 y | 5-year | -60.8% | +42.1% | -170.2% | +96.8% | -1320.3% | at low |
| alltime | all time | -839.1% | +92.3% | -128.1% | +98.9% | -3582.9% | +63.7% |
Integra LifeSciences Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.40 M(-96.8%) | -$443.79 M(+0.6%) |
| Jun 2024 | - | -$322.20 M(+497.0%) | -$441.09 M(+228.1%) |
| Mar 2024 | - | -$53.97 M(-5.7%) | -$134.44 M(+42.7%) |
| Dec 2023 | -$94.18 M(+60.8%) | -$57.23 M(+643.5%) | -$94.18 M(+2.6%) |
| Sep 2023 | - | -$7.70 M(-50.5%) | -$91.77 M(+32.5%) |
| Jun 2023 | - | -$15.55 M(+13.5%) | -$69.27 M(+19.0%) |
| Mar 2023 | - | -$13.70 M(-75.0%) | -$58.22 M(-0.6%) |
| Dec 2022 | -$58.58 M(-63.7%) | -$54.82 M(-470.3%) | -$58.58 M(+87.5%) |
| Sep 2022 | - | $14.80 M(-429.1%) | -$31.25 M(-42.7%) |
| Jun 2022 | - | -$4.50 M(-68.0%) | -$54.52 M(-5.9%) |
| Mar 2022 | - | -$14.07 M(-48.8%) | -$57.94 M(-64.1%) |
| Dec 2021 | -$161.44 M(+137.2%) | -$27.48 M(+224.3%) | -$161.44 M(-5.0%) |
| Sep 2021 | - | -$8.47 M(+7.0%) | -$169.88 M(+1.0%) |
| Jun 2021 | - | -$7.92 M(-93.3%) | -$168.12 M(+2.4%) |
| Mar 2021 | - | -$117.57 M(+227.3%) | -$164.15 M(+141.1%) |
| Dec 2020 | -$68.07 M(-58.2%) | -$35.92 M(+434.7%) | -$68.07 M(+29.0%) |
| Sep 2020 | - | -$6.72 M(+70.1%) | -$52.76 M(-65.9%) |
| Jun 2020 | - | -$3.95 M(-81.6%) | -$154.88 M(-8.0%) |
| Mar 2020 | - | -$21.48 M(+4.3%) | -$168.35 M(+3.5%) |
| Dec 2019 | -$162.67 M(+227.3%) | -$20.61 M(-81.1%) | -$162.67 M(-2.8%) |
| Sep 2019 | - | -$108.84 M(+525.0%) | -$167.39 M(+123.5%) |
| Jun 2019 | - | -$17.41 M(+10.2%) | -$74.89 M(+33.2%) |
| Mar 2019 | - | -$15.81 M(-37.6%) | -$56.21 M(+13.1%) |
| Dec 2018 | -$49.70 M(-95.9%) | -$25.33 M(+55.0%) | -$49.70 M(-95.1%) |
| Sep 2018 | - | -$16.34 M(-1390.9%) | -$1.01 B(+0.9%) |
| Jun 2018 | - | $1.27 M(-113.6%) | -$998.71 M(-3.7%) |
| Mar 2018 | - | -$9.30 M(-99.1%) | -$1.04 B(-15.1%) |
| Dec 2017 | -$1.22 B(+2765.5%) | -$983.57 M(>+9900.0%) | -$1.22 B(+371.7%) |
| Sep 2017 | - | -$7.11 M(-81.1%) | -$258.91 M(+0.2%) |
| Jun 2017 | - | -$37.52 M(-80.6%) | -$258.51 M(+12.9%) |
| Mar 2017 | - | -$193.14 M(+813.6%) | -$229.03 M(+437.4%) |
| Dec 2016 | -$42.62 M(-88.5%) | -$21.14 M(+215.2%) | -$42.62 M(-28.1%) |
| Sep 2016 | - | -$6.71 M(-16.6%) | -$59.30 M(-83.9%) |
| Jun 2016 | - | -$8.04 M(+19.5%) | -$368.04 M(-1.4%) |
| Mar 2016 | - | -$6.73 M(-82.2%) | -$373.11 M(+0.3%) |
| Dec 2015 | -$372.01 M(+2.4%) | -$37.82 M(-88.0%) | -$372.01 M(-14.1%) |
| Sep 2015 | - | -$315.45 M(+2305.8%) | -$433.04 M(+242.7%) |
| Jun 2015 | - | -$13.11 M(+132.8%) | -$126.37 M(+3.1%) |
| Mar 2015 | - | -$5.63 M(-94.3%) | -$122.61 M(-66.3%) |
| Dec 2014 | -$363.32 M(+622.4%) | -$98.85 M(+1026.5%) | -$363.32 M(+32.3%) |
| Sep 2014 | - | -$8.78 M(-6.2%) | -$274.59 M(-1.7%) |
| Jun 2014 | - | -$9.36 M(-96.2%) | -$279.21 M(-1.5%) |
| Mar 2014 | - | -$246.34 M(+2332.5%) | -$283.54 M(+463.8%) |
| Dec 2013 | -$50.30 M(-36.6%) | -$10.13 M(-24.4%) | -$50.30 M(-28.1%) |
| Sep 2013 | - | -$13.39 M(-2.1%) | -$69.94 M(+90.6%) |
| Jun 2013 | - | -$13.69 M(+4.6%) | -$36.69 M(+28.6%) |
| Mar 2013 | - | -$13.09 M(-56.0%) | -$28.53 M(-64.0%) |
| Dec 2012 | -$79.28 M(-58.4%) | -$29.77 M(-250.0%) | -$79.28 M(+21.8%) |
| Sep 2012 | - | $19.86 M(-459.5%) | -$65.08 M(-60.7%) |
| Jun 2012 | - | -$5.52 M(-91.3%) | -$165.80 M(-33.2%) |
| Mar 2012 | - | -$63.84 M(+309.9%) | -$248.29 M(+30.4%) |
| Dec 2011 | -$190.38 M(+349.9%) | -$15.57 M(-80.7%) | -$190.38 M(-1.9%) |
| Sep 2011 | - | -$80.86 M(-8.1%) | -$194.05 M(+58.9%) |
| Jun 2011 | - | -$88.02 M(+1386.2%) | -$122.14 M(+188.8%) |
| Mar 2011 | - | -$5.92 M(-69.2%) | -$42.29 M(-0.1%) |
| Dec 2010 | -$42.32 M | -$19.25 M(+114.9%) | -$42.32 M(-53.2%) |
| Sep 2010 | - | -$8.96 M(+9.6%) | -$90.35 M(+0.3%) |
| Jun 2010 | - | -$8.17 M(+37.4%) | -$90.05 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$5.94 M(-91.2%) | -$87.25 M(-1.3%) |
| Dec 2009 | -$88.35 M(-11.9%) | -$67.28 M(+677.1%) | -$88.35 M(+158.3%) |
| Sep 2009 | - | -$8.66 M(+61.5%) | -$34.21 M(-67.9%) |
| Jun 2009 | - | -$5.36 M(-23.9%) | -$106.55 M(+2.0%) |
| Mar 2009 | - | -$7.05 M(-46.3%) | -$104.47 M(+4.2%) |
| Dec 2008 | -$100.28 M(-18.5%) | -$13.14 M(-83.8%) | -$100.28 M(-36.1%) |
| Sep 2008 | - | -$81.00 M(+2365.0%) | -$156.84 M(+90.4%) |
| Jun 2008 | - | -$3.29 M(+15.3%) | -$82.36 M(-31.2%) |
| Mar 2008 | - | -$2.85 M(-95.9%) | -$119.65 M(-2.7%) |
| Dec 2007 | -$122.97 M(-13.8%) | -$69.71 M(+969.9%) | -$122.97 M(+110.5%) |
| Sep 2007 | - | -$6.51 M(-83.9%) | -$58.41 M(-32.6%) |
| Jun 2007 | - | -$40.58 M(+557.3%) | -$86.69 M(-6.2%) |
| Mar 2007 | - | -$6.17 M(+20.0%) | -$92.39 M(-35.3%) |
| Dec 2006 | -$142.69 M(+362.7%) | -$5.14 M(-85.2%) | -$142.69 M(+25.2%) |
| Sep 2006 | - | -$34.80 M(-24.8%) | -$113.98 M(+34.5%) |
| Jun 2006 | - | -$46.27 M(-18.1%) | -$84.75 M(+142.2%) |
| Mar 2006 | - | -$56.48 M(-339.7%) | -$34.99 M(+13.5%) |
| Dec 2005 | -$30.84 M(-342.0%) | $23.57 M(-523.9%) | -$30.84 M(+76.8%) |
| Sep 2005 | - | -$5.56 M(-259.6%) | -$17.44 M(+147.5%) |
| Jun 2005 | - | $3.48 M(-106.7%) | -$7.05 M(-68.6%) |
| Mar 2005 | - | -$52.33 M(-241.6%) | -$22.41 M(-275.8%) |
| Dec 2004 | $12.74 M(-113.5%) | $36.97 M(+664.9%) | $12.74 M(-133.2%) |
| Sep 2004 | - | $4.83 M(-140.7%) | -$38.43 M(-54.7%) |
| Jun 2004 | - | -$11.88 M(-30.9%) | -$84.87 M(-11.0%) |
| Mar 2004 | - | -$17.18 M(+20.9%) | -$95.34 M(+1.1%) |
| Dec 2003 | -$94.33 M(+204.5%) | -$14.21 M(-65.9%) | -$94.33 M(-3.6%) |
| Sep 2003 | - | -$41.61 M(+86.2%) | -$97.83 M(+48.4%) |
| Jun 2003 | - | -$22.34 M(+38.1%) | -$65.94 M(+41.8%) |
| Mar 2003 | - | -$16.18 M(-8.6%) | -$46.50 M(+50.1%) |
| Dec 2002 | -$30.98 M(-67.3%) | -$17.70 M(+82.2%) | -$30.98 M(-19.1%) |
| Sep 2002 | - | -$9.71 M(+234.5%) | -$38.30 M(-57.1%) |
| Jun 2002 | - | -$2.90 M(+341.3%) | -$89.34 M(-3.0%) |
| Mar 2002 | - | -$658.00 K(-97.4%) | -$92.11 M(-2.8%) |
| Dec 2001 | -$94.74 M(+553.3%) | -$25.02 M(-58.8%) | -$94.74 M(+38.8%) |
| Sep 2001 | - | -$60.76 M(+971.5%) | -$68.25 M(+725.2%) |
| Jun 2001 | - | -$5.67 M(+72.5%) | -$8.27 M(-51.3%) |
| Mar 2001 | - | -$3.29 M(-323.0%) | -$16.98 M(+17.1%) |
| Dec 2000 | -$14.50 M(-4084.3%) | $1.47 M(-287.5%) | -$14.50 M(+13.2%) |
| Sep 2000 | - | -$786.00 K(-94.5%) | -$12.81 M(+22.9%) |
| Jun 2000 | - | -$14.39 M(+1687.1%) | -$10.43 M(-333.8%) |
| Mar 2000 | - | -$805.00 K(-125.4%) | $4.46 M(+1125.0%) |
| Dec 1999 | $364.00 K(-96.1%) | $3.16 M(+97.8%) | $364.00 K(-87.2%) |
| Sep 1999 | - | $1.60 M(+220.0%) | $2.85 M(+96.8%) |
| Jun 1999 | - | $500.00 K(-110.2%) | $1.45 M(-187.4%) |
| Mar 1999 | - | -$4.90 M(-186.8%) | -$1.65 M(-117.9%) |
| Dec 1998 | $9.25 M(-520.3%) | $5.65 M(+2723.0%) | $9.25 M(+560.4%) |
| Sep 1998 | - | $200.00 K(-107.7%) | $1.40 M(-79.4%) |
| Jun 1998 | - | -$2.60 M(-143.3%) | $6.80 M(+15.3%) |
| Mar 1998 | - | $6.00 M(-372.7%) | $5.90 M(-368.2%) |
| Dec 1997 | -$2.20 M(-89.7%) | -$2.20 M(-139.3%) | -$2.20 M(-137.9%) |
| Sep 1997 | - | $5.60 M(-260.0%) | $5.80 M(>+9900.0%) |
| Jun 1997 | - | -$3.50 M(+66.7%) | $0.00(-100.0%) |
| Mar 1997 | - | -$2.10 M(-136.2%) | $3.40 M(-116.0%) |
| Dec 1996 | -$21.30 M(-449.2%) | $5.80 M(-3000.0%) | -$21.30 M(-21.4%) |
| Sep 1996 | - | -$200.00 K(+100.0%) | -$27.10 M(+0.7%) |
| Jun 1996 | - | -$100.00 K(-99.6%) | -$26.90 M(+0.4%) |
| Mar 1996 | - | -$26.80 M | -$26.80 M |
| Dec 1995 | $6.10 M | - | - |
FAQ
- What is Integra LifeSciences Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual CFI year-on-year change?
- What is Integra LifeSciences Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly CFI year-on-year change?
- What is Integra LifeSciences Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM CFI year-on-year change?
What is Integra LifeSciences Holdings annual cash flow from investing activities?
The current annual CFI of IART is -$94.18 M
What is the all time high annual CFI for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual cash flow from investing activities is $12.74 M
What is Integra LifeSciences Holdings annual CFI year-on-year change?
Over the past year, IART annual cash flow from investing activities has changed by -$35.60 M (-60.77%)
What is Integra LifeSciences Holdings quarterly cash flow from investing activities?
The current quarterly CFI of IART is -$10.40 M
What is the all time high quarterly CFI for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly cash flow from investing activities is $36.97 M
What is Integra LifeSciences Holdings quarterly CFI year-on-year change?
Over the past year, IART quarterly cash flow from investing activities has changed by -$2.70 M (-35.07%)
What is Integra LifeSciences Holdings TTM cash flow from investing activities?
The current TTM CFI of IART is -$443.79 M
What is the all time high TTM CFI for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM cash flow from investing activities is $12.74 M
What is Integra LifeSciences Holdings TTM CFI year-on-year change?
Over the past year, IART TTM cash flow from investing activities has changed by -$352.02 M (-383.59%)